Literature DB >> 19540008

Is African descent an independent risk factor of peripartum cardiomyopathy?

C Godard Sebillotte, C Deligny, M Hanf, R Santiago, J C Chevallier, J L Voluménie, S Arfi.   

Abstract

Risk factors for peripartum cardiomyopathy (PPCM) are controversial. PPCM seems to be more prevalent in women of African descent, the highest observed incidence is in Haiti (1 per 300 live births). Our retrospective study conducted in Martinique showed an incidence of 1 per 5500 live births. This incidence is significantly lower than in Haiti. Women from Martinique and Haiti do not differ for most classical risk factors: African descent, age, pregnancy-associated hypertension, multiple pregnancy and pre-eclampsia. However, the parity rate and the socioeconomic level are different. Thus, African descent could be confounded by high parity rate and socioeconomic status.

Entities:  

Mesh:

Year:  2009        PMID: 19540008     DOI: 10.1016/j.ijcard.2009.05.042

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  The Role of Genetics in Peripartum Cardiomyopathy.

Authors:  Yi Zhen Joan Lee; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2017-08-03       Impact factor: 4.132

Review 2.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

3.  Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study.

Authors:  Paul Leménager; Yves-Kenol Franck; Florine Corlin; Nicolas Bouscaren; Mathieu Nacher; Antoine Adenis
Journal:  Open Heart       Date:  2020-05

Review 4.  Peripartum cardiomyopathy: current state of knowledge, new developments and future directions.

Authors:  Murat Biteker; Kadir Kayatas; Dursun Duman; Muhsin Turkmen; Biykem Bozkurt
Journal:  Curr Cardiol Rev       Date:  2014-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.